Pharmacy Innovations recalls METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/METHYLCOBAL 15MG/5
Recalled February 1, 2023 · FDA recall D-0220-2023 · Pharmacy Innovations
Hazard
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. · FDA Class II
Units
N/A
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Product
METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/METHYLCOBAL 15MG/50MG/100MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/RIBOFLA/NIACINAMIDE/PYRIDOX/ASCORBIC ACID 15.625MG/31.25MG/31.25MG/6.25MG/62.5MG/6.25MG/62.5MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Manufacturer(s)
Pharmacy Innovations
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →